GL1X · GenesisL1 explorer

MolNFT v1 · #5951 · protein

Enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the inactive S-enantiomer BMS270395.

1EXX · Retinoic acid receptor gamma-2: “Enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma…”. X-ray diffraction, 2 ligands (961, LMU), 4 pockets (best druggability 0.81). MolNFT v1…

PDB
1EXX
Type
protein
Length
236 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor gamma-2
UniProt
P22932
Ligands
961, LMU
Pockets
4 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor gamma-2protein23667% helix, 4% strandP22932

Ligands and binding sites

  • 961 · 3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid · ligand · chains A
  • LMU · Dodecyl-alpha-D-maltoside · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12080.810.9434961
21180.500.8019empty
3840.400.7715empty
4660.290.7412empty

Compared structures

  • 1EXX · Enantiomer discrimination illustrated by crystal structures of the human retinoic acid… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.